Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H32O5 |
Molecular Weight | 352.4651 |
Optical Activity | ( - ) |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O
InChI
InChIKey=XEYBRNLFEZDVAW-ARSRFYASSA-N
InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1
Molecular Formula | C20H32O5 |
Molecular Weight | 352.4651 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 2 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:12:48 UTC 2023
by
admin
on
Fri Dec 15 15:12:48 UTC 2023
|
Record UNII |
K7Q1JQR04M
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
12836-3
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
||
|
LOINC |
70091-4
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
||
|
LOINC |
2853-0
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
||
|
NCI_THESAURUS |
C78568
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
||
|
WHO-ATC |
G02AD02
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
||
|
LOINC |
14006-1
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
||
|
NCI_THESAURUS |
C782
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
||
|
NDF-RT |
N0000007706
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
||
|
WHO-VATC |
QG02AD02
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
||
|
NDF-RT |
N0000007706
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
||
|
NDF-RT |
N0000175454
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
||
|
NDF-RT |
N0000007706
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB07195MIG
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
K7Q1JQR04M
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
196514
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
100000092220
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
DTXSID4022947
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
206-656-6
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
PROSTAGLANDIN E2
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
363-24-6
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
165560
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
3478
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | RxNorm | ||
|
K7Q1JQR04M
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
913
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
1883
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
Dinoprostone
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
606564
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
D015232
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
CHEMBL548
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
1213103
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
m9258
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | Merck Index | ||
|
DB00917
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
3075
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
5280360
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
15551
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY | |||
|
C61727
Created by
admin on Fri Dec 15 15:12:48 UTC 2023 , Edited by admin on Fri Dec 15 15:12:48 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
||
|
LABELED -> NON-LABELED |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
INHIBITOR -> TARGET |
|
||
|
TARGET -> AGONIST |
Ki
|
||
|
TARGET -> AGONIST |
Ki
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
TARGET -> AGONIST |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
EP
|
||
|
TARGET -> AGONIST |
|
||
|
TARGET -> AGONIST |
Ki
|
||
|
TARGET -> AGONIST |
Ki
|
||
|
TARGET -> AGONIST |
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 0.7
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
For the calculation of contents, multiply the peak areas by 0.2
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
The sum of these three impurities is NMT 1.0%. (15-Oxo-dinoprostone, 15-Epi-dinoprostone,and 8-Isodinoprostone)
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
The sum of these three impurities is NMT 1.0%. (15-Oxo-dinoprostone, 15-Epi-dinoprostone,and 8-Isodinoprostone)
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
The sum of these three impurities is NMT 1.0%. (15-Oxo-dinoprostone, 15-Epi-dinoprostone,and 8-Isodinoprostone)
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|